Michael Watson

2.9k total citations · 2 hit papers
47 papers, 2.1k citations indexed

About

Michael Watson is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Michael Watson has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 14 papers in Infectious Diseases and 9 papers in Microbiology. Recurrent topics in Michael Watson's work include Pneumonia and Respiratory Infections (13 papers), Influenza Virus Research Studies (9 papers) and Bacterial Infections and Vaccines (9 papers). Michael Watson is often cited by papers focused on Pneumonia and Respiratory Infections (13 papers), Influenza Virus Research Studies (9 papers) and Bacterial Infections and Vaccines (9 papers). Michael Watson collaborates with scholars based in Australia, United States and France. Michael Watson's co-authors include Tal Zaks, James D. Thompson, Mike Smith, Giuseppe Ciaramella, Örn Almarsson, Michael E. Laska, Olga Yuzhakov, Kapil Bahl, Kimberly J. Hassett and Alex Bulychev and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Trends in Biochemical Sciences.

In The Last Decade

Michael Watson

45 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

2017 493 citations Kapil Bahl, Olga Yuzhakov et al. Molecular Therapy profile →
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

2019 331 citations Michael Watson, Mike Smith et al. Vaccine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Watson Australia	21	843	710	616	320	252	47	2.1k
Jonathan Hartzel United States	22	830 1.0×	473 0.7×	211 0.3×	144 0.5×	204 0.8×	44	1.8k
Jesús Ruíz-Contreras Spain	24	1.1k 1.3×	502 0.7×	184 0.3×	367 1.1×	330 1.3×	146	1.9k
Tino F. Schwarz Germany	33	2.1k 2.5×	1.6k 2.2×	529 0.9×	542 1.7×	160 0.6×	132	4.0k
Timothy R. Peters United States	19	614 0.7×	534 0.8×	249 0.4×	154 0.5×	96 0.4×	54	1.5k
Lori Panther United States	21	721 0.9×	611 0.9×	355 0.6×	198 0.6×	79 0.3×	40	1.5k
Paul‐Henri Lambert Switzerland	22	612 0.7×	557 0.8×	337 0.5×	938 2.9×	152 0.6×	32	1.9k
Eftyhia Vardas South Africa	23	1.5k 1.8×	493 0.7×	341 0.6×	440 1.4×	83 0.3×	52	2.4k
Simon Beddows United Kingdom	35	1.6k 1.9×	1.0k 1.5×	516 0.8×	955 3.0×	513 2.0×	88	3.6k
Pierre Vandepapelière Belgium	23	1.4k 1.7×	349 0.5×	298 0.5×	923 2.9×	166 0.7×	35	2.3k
Igor Smolenov United States	20	588 0.7×	1.0k 1.4×	365 0.6×	248 0.8×	284 1.1×	59	1.7k

Countries citing papers authored by Michael Watson

Since Specialization

Citations

This map shows the geographic impact of Michael Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Watson more than expected).

Fields of papers citing papers by Michael Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Watson. The network helps show where Michael Watson may publish in the future.

Co-authorship network of co-authors of Michael Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Watson. A scholar is included among the top collaborators of Michael Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Watson. Michael Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watson, Michael, et al.. (2024). Sonographic features of sternal pseudotumour in children. Australasian Journal of Ultrasound in Medicine. 27(2). 124–130.

Hoad, Veronica C., et al.. (2019). Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. “Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country” [Transfus Med Hemother. 2019 Apr;46(2):104–10]. Transfusion Medicine and Hemotherapy. 47(3). 272–274. 3 indexed citations

Watson, Michael, et al.. (2018). Relationship between Spiritually Intelligent Leadership and Employee Engagement. Journal of Marketing Management. 9(2). 1. 3 indexed citations

Watson, Michael. (2018). Panel discussion on the application of MCDA tools. Cost Effectiveness and Resource Allocation. 16(S1). 40–40. 2 indexed citations

Bahl, Kapil, Olga Yuzhakov, Alex Bulychev, et al.. (2017). Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses. Molecular Therapy. 25(6). 1316–1327. 493 indexed citations breakdown →

Saadatian‐Elahi, Mitra, David E. Bloom, Stanley A. Plotkin, et al.. (2017). Vaccination ecosystem health check: achieving impact today and sustainability for tomorrow. BMC Proceedings. 11(S2). 1–1. 5 indexed citations

Burgess, Teresa, Annette Braunack‐Mayer, Rebecca Tooher, et al.. (2015). Optimizing intersectoral collaboration between health and education: the Health Bridges study. Journal of Public Health. 38(4). fdv190–fdv190. 19 indexed citations

Lehmann, Deborah, Hannah C. Moore, Carolien Giele, et al.. (2010). The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes. Clinical Infectious Diseases. 50(11). 1477–1486. 68 indexed citations

Reinert, Philippe, Sandro Cinquetti, B. Soubeyrand, et al.. (2010). Challenge with hepatitis B vaccine in children previously vaccinated with a hepatitis B-containing combination vaccine. Advances in Therapy. 27(1). 28–38. 5 indexed citations

10.

Halliday, William, et al.. (2007). Cortical ependymoma or monomorphous angiocentric glioma?. Neuropathology. 28(1). 81–86. 28 indexed citations

11.

Watson, Michael, et al.. (2007). Pneumococci responsible for invasive disease and discharging ears in children in Sydney, Australia. Journal of Medical Microbiology. 56(6). 819–823. 8 indexed citations

12.

Reinert, Philippe, et al.. (2006). Fever as a Marker of Reactogenicity of an Acellular Pertussis-Containing Hexavalent Vaccine (HEXAVAC®) in a Large-Scale, Open, Randomized Safety Study in Healthy French Infants. Human Vaccines. 2(5). 215–221. 4 indexed citations

13.

Kitchin, Nicholas, Jo Southern, Rhonwen Morris, et al.. (2006). A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with meningococcal group C conjugate vaccine to healthy UK infants at 2, 3 and 4 months of age. Vaccine. 24(18). 3964–3970. 24 indexed citations

14.

Chomarat, M., et al.. (2005). Étude du portage rhinopharyngé de Streptococcus pneumoniae chez les enfants sains âgés de 2 à 24 mois en Nouvelle-Calédonie. Médecine et Maladies Infectieuses. 35(10). 500–506. 10 indexed citations

15.

Stewart, Ronald M., Yuko Ohta, Ralph Minter, et al.. (2005). Cloning and characterization of ?2-microglobulin. Developmental & Comparative Immunology. 29(8). 723–732. 12 indexed citations

16.

Lin, Kevin M., Tarak H. Patel, Adrian S. Ray, et al.. (2004). Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. Journal of the American College of Surgeons. 199(4). 561–566. 47 indexed citations

17.

Wallace, L A, S. Faisal Ahmed, William F. Carman, et al.. (2002). Universal hepatitis B vaccination of UK adolescents: a feasibility and acceptability study.. PubMed. 5(4). 318–20. 14 indexed citations

18.

Watson, Michael, et al.. (2002). Lemierre syndrome due to non‐multiresistant methicillin‐resistant Staphylococcus aureus. Journal of Paediatrics and Child Health. 38(3). 305–307. 21 indexed citations

19.

Watson, Michael, et al.. (2002). Staphylococcus aureus bacteraemia in children: A 5‐year retrospective review. Journal of Paediatrics and Child Health. 38(3). 290–294. 56 indexed citations

20.

Yang, Yih‐Ming, et al.. (1995). Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients.. PubMed. 110(1). 80–6. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact